Evidence map›Paper›PMID 28540815›Full record

ArticleInternational journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group2018

Computation of ultimate SAR amplification factors for radiofrequency hyperthermia in non-uniform body models: impact of frequency and tumour location.

Bastien Guérin, Jorge F Villena, Athanasios G Polimeridis, Elfar Adalsteinsson, Luca Daniel, Jacob K White, Bruce R Rosen, Lawrence L Wald

Open access · bronzeAbstract read
In one paragraph

Article in International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Radiofrequency applicator concepts for thermal magnetic resonance of brain tumors at 297 MHz (7.0 Tesla).International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Bastien Guérina Martinos Center for Biomedical Imaging, Department of Radiology , Massachusetts General Hospital , Charlestown , MA , USA.
Jorge F Villenac Cadence Design Systems , Feldkirchen , Germany.
Athanasios G Polimeridisd Skolkovo Institute of Science and Technology , Moscow , Russia.
Elfar Adalsteinssone Research Laboratory of Electronics , Massachusetts Institute of Technology , Cambridge , MA , USA.
Luca Daniele Research Laboratory of Electronics , Massachusetts Institute of Technology , Cambridge , MA , USA.
Jacob K Whitee Research Laboratory of Electronics , Massachusetts Institute of Technology , Cambridge , MA , USA.
Bruce R Rosena Martinos Center for Biomedical Imaging, Department of Radiology , Massachusetts General Hospital , Charlestown , MA , USA.
Lawrence L Walda Martinos Center for Biomedical Imaging, Department of Radiology , Massachusetts General Hospital , Charlestown , MA , USA.
Harvard University · USMassachusetts Institute of Technology · USCadence Design Systems (Germany) · DESkolkovo Institute of Science and Technology · RU

Funding

Parallel Excitation Methods for High Field MRIR01EB006847 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI WALD, LAWRENCE L · 2007 to 2020
$5.4M
Neuroimaging of deep brain stimulation patients using safe MRI excitationsR00EB019482 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI GUERIN, BASTIEN · 2017 to 2019
$747k
Neuroimaging of deep brain stimulation patients using safe MRI excitationsK99EB019482 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI GUERIN, BASTIEN · 2015 to 2016
$188k
NIBIB NIH HHS K99 EB019482NIBIB NIH HHS R00 EB019482NIBIB NIH HHS R01 EB006847
6 · The paper itself

Abstract

purposeWe introduce a method for calculation of the ultimate specific absorption rate (SAR) amplification factors (uSAF) in non-uniform body models. The uSAF is the greatest possible SAF achievable by any hyperthermia (HT) phased array for a given frequency, body model and target heating volume.

methodsFirst, we generate a basis-set of solutions to Maxwell's equations inside the body model. We place a large number of electric and magnetic dipoles around the body model and excite them with random amplitudes and phases. We then compute the electric fields created in the body model by these excitations using an ultra-fast volume integral solver called MARIE. We express the field pattern that maximises the SAF in the target tumour as a linear combination of these basis fields and optimise the combination weights so as to maximise SAF (concave problem). We compute the uSAFs in the Duke body models at 10 frequencies in the 20-900 MHz range and for twelve 3 cm-diameter tumours located at various depths in the head and neck.

resultsFor both shallow and deep tumours, the frequency yielding the greatest uSAF was ∼900 MHz. Since this is the greatest frequency that we simulated, we hypothesise that the globally optimal frequency is actually greater.

conclusionsThe uSAFs computed in this work are very large (40-100 for shallow tumours and 4-17 for deep tumours), indicating that there is a large room for improvement of the current state-of-the-art head and neck HT devices.

Indexed as

Electromagnetic PhenomenaRadiofrequency TherapyHumansHyperthermia, InducedNeoplasmsfrequency of the treatment energySAR amplification factorthermal dosetumour depthUltimate electromagnetics

Identifiers

PMID28540815
PMCPMC5681886
OpenAlexW2605537173

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.